• CFS™ for Ligaments
• CFS™ for Horses

CFS^TM for Treatment of Knee-Ligament Injuries. Pre- Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 7: Correspondence, 1992. [PDF]

CFS^TM for Treatment of Knee-Ligament Injuries. Pre- Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 6: Literature Analysis and Overall Analysis, 1992. [PDF]

CFS^TM for Treatment of Knee-Ligament Injuries. Pre- Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 5: Other Clinical Investigations, 1992. [PDF]

CFS^TM for Treatment of Knee-Ligament Injuries. Pre- Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 4: Plastafil Clinical Investigations, 1992. [PDF]

CFS^TM for Treatment of Knee-Ligament Injuries. Pre- Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 3: Mechanical, Microbiological, & Animal Testing, 1992. [PDF]

CFS^TM for Treatment of Knee-Ligament Injuries. Pre- Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 2: Device Characteristics & Manufacturing, 1992. [PDF]

CFS^TM for Treatment of Knee-Ligament Injuries. Pre-Market Application to U.S. Food and Drug Administration.
Plastafil, Inc. Volume 1: Summary of Safety and Effectiveness Data, 1992. [PDF]